The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSQN.L Regulatory News (SQN)

  • There is currently no data for SQN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

19 Apr 2017 10:40

RNS Number : 7131C
SQN Asset Finance Income Fund Ltd
19 April 2017
 

This announcement contains inside information

 

19 April 2017

 

 

SQN Asset Finance Income Fund Limited

 

Portfolio Update

 

SQN Asset Finance Income Fund Limited (the "Company" or "SQN"), the leading diversified equipment leasing fund listed in the UK provides the following portfolio update.

 

In August 2015, SQN agreed a 5 year financing arrangement with a US solar cell manufacturing company that was secured against its manufacturing and production equipment and supported by a parental guarantee from a public company. In the NAV as at 28 February 2017, being the last published NAV, the amount outstanding to the Company was $29.9m (£24.1m), which represents approximately 6.8 per cent. of the net assets of the ordinary share class.

 

At the time of the investment, the manufacturer had been producing and selling solar cells at attractive price levels and was positioned to improve its margins even in an environment of predictably decreasing sale prices. However, there has been a rapid decline in the market price for solar cells driven by imports flooding the US markets in contravention of established international trade agreements and in circumvention of tariffs put in place to protect the US solar industry.

 

The scheduled payment on this investment due to the Company on 31 March 2017 has not been made and SQN was recently notified that, as a result of the impact of the falling solar cell prices and a temporary increase in the cost of production, the manufacturer has suspended production while it seeks redress from the United States International Trade Commission under the Trade Act of 1974, Import Relief for Domestic Industries (the "US Trade Act").

 

A resolution has been put forward to SQN, pursuant to which, a petition would be made under Section 201 of the US Trade Act which would provide specific relief for a period of four years which, if granted, would enable the investee business to return to trading profitably and make it an attractive acquisition target. In such a scenario, it is expected that SQN would make a full recovery of its principal plus all current and future interest, as well as have an interest in the on-going enterprise.

 

The Company has reached an agreement with the manufacturer to enter into protective bankruptcy under Chapter 11 of the United States Bankruptcy Code in which SQN will provide an agreed amount of additional financing to the manufacturer under a 'debtor-in-possession' motion and have oversight of the manufacturer while the trade case is being pursued. There is a prescribed timeframe for action under a Section 201 petition which dictates that a resolution should be reached by the end of 2017. At the same time, the Company has made demand for payment under the guarantee from the parent company of the manufacturer. 

 

While there can be no certainty that a favourable decision on the trade case will be reached, the Manager, the Company, the manufacturer, its advisors, its counsel, and certain members of the US government in relevant trade capacities all believe that there is a legitimate case and, as such, the Company believes this presents a more attractive option to pursue than seeking to enforce its security at this time. If a favourable decision is not reached, the Company could experience a principal loss in the event that the amount recovered through the parental guarantee and the proceeds received from the sale of the equipment are less than the outstanding exposure.

 

The Manager and the Board will continue to monitor the situation closely and review the need for any impairment as the trade case progresses.

 

It is expected that the Company will not receive income from this investment, which is exclusively part of the ordinary shares portfolio, for 9 to 12 months as this matter is resolved. However, in the absence of unforeseen circumstances, the Company should have sufficient excess income from other investments in the ordinary shares portfolio to maintain its dividend at the current level.

 

For further information please contact:

 

 

SQN Capital Management, LLC

Jeremiah Silkowski

Neil Roberts

 

+44 (0)1932 575 888

Winterflood Securities Limited

Neil Langford

Chris Mills

 

+44 (0)20 3100 0000

Buchanan

Charles Ryland

Vicky Hayns

+44(0) 207 466 5000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUGIGDSSUBBGRC
Date   Source Headline
17th Jul 20202:58 pmRNSChange of Name
16th Jul 202012:38 pmRNSResult of EGM and Class Meetings
8th Jul 20207:00 amRNSInvestment Update
24th Jun 20207:00 amRNSNet Asset Value(s)
17th Jun 20203:02 pmRNSHolding(s) in Company
16th Jun 20207:00 amRNSContinuation Vote and Publication of Circular
8th Jun 20207:00 amRNSAppointment of Investment Manager
22nd May 20207:00 amRNSNet Asset Value(s)
5th May 202012:03 pmRNSDisclosure of rights attached to listed securities
30th Apr 20207:00 amRNSConclusion of Strategic Review & Change of Manager
24th Apr 20202:23 pmRNSMonthly Net Asset Value and Covid-19 update
14th Apr 202011:35 amRNSHolding(s) in Company
6th Apr 20204:42 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
3rd Apr 20203:21 pmRNSHalf-Yearly Report
1st Apr 20208:51 amRNSHalf-year Report - Delay in publication
31st Mar 20202:13 pmRNSJanuary and February Net Asset Values
31st Mar 20201:01 pmRNSOutcome of KPMG Review & Release of December NAV
24th Mar 20207:00 amRNSMonthly Net Asset Value and Dividend
18th Mar 202011:32 amRNSUpdate on Dividends
18th Mar 20207:00 amRNSForeign Exchange Hedging
5th Mar 20207:00 amRNSConclusion of a further Anaerobic Digestion plant
25th Feb 20207:00 amRNSBoard Responsibilities
21st Feb 20207:00 amRNSNet Asset Value and Dividend
13th Feb 20207:00 amRNSUpdate on AD Plant Valuation & Strategic Review
12th Feb 20207:00 amRNSMarket Update
5th Feb 202011:25 amRNSHolding(s) in Company
28th Jan 202010:08 amRNSStrategic Review Update
27th Jan 202011:40 amRNSHolding(s) in Company
24th Jan 20207:00 amRNSMonthly Net Asset Value and Dividend
24th Jan 20207:00 amRNSStrategic Review
20th Jan 20208:26 amRNSAnaerobic Digestion Assets
2nd Jan 202010:58 amRNSTotal Voting Rights
20th Dec 20197:00 amRNSNet Asset Value and Dividend
11th Dec 20195:43 pmRNSTransaction in Own Shares
9th Dec 20194:46 pmRNSTransaction in Own Shares
5th Dec 20193:51 pmRNSTransaction in Own Shares (Replacement)
4th Dec 20196:00 pmRNSDirectorate Change
4th Dec 20197:30 amRNSTransaction in Own Shares
2nd Dec 20195:01 pmRNSTransaction in Own Shares
28th Nov 20195:30 pmRNSTransaction in Own Shares
22nd Nov 20197:00 amRNSNet Asset Value and Dividend
21st Nov 20194:21 pmRNSResult of AGM and Class Meetings
28th Oct 20194:02 pmRNSNotice of AGM and Class Meetings
28th Oct 20197:00 amRNSMonthly NAV and Dividend
25th Oct 20192:28 pmRNSHolding(s) in Company
8th Oct 20194:38 pmRNSAnnual Financial Report (Replacement)
2nd Oct 201912:01 pmRNSNet Asset Value and Dividend (replacment)
30th Sep 20197:01 amRNSAnnual Financial Report
30th Sep 20197:00 amRNSNet Asset Value and Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.